The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Institutional Affiliations Co-chairs Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of Alabama at Birmingham, Birmingham, Alabama; Teuteberg JJ: University of Pittsburgh, Pittsburgh, Pennsylvania Task force chairs Birks E: University of Louisville, Louisville, Kentucky; Lietz K: Loyola University, Chicago, Maywood, Illinois; Moore SA: Massachusetts General Hospital, Boston, Massachusetts; Morgan JA: Henry Ford Hospital, Detroit, Michigan Contributing writers Arabia F: Mayo Clinic Arizona, Phoenix, Arizona; Bauman ME: University of Alberta, Alberta, Canada; Buchholz HW: University of Alberta, Stollery Children’s Hospital and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada; Deng M: University of California at Los Angeles, Los Angeles, California; Dickstein ML: Columbia University, New York, New York; El-Banayosy A: Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania; Elliot T: Inova Fairfax, Falls Church, Virginia; Goldstein DJ: Montefiore Medical Center, New York, New York; Grady KL: Northwestern University, Chicago, Illinois; Jones K: Alfred Hospital, Melbourne, Australia; Hryniewicz K: Minneapolis Heart Institute, Minneapolis, Minnesota; John R: University of Minnesota, Minneapolis, Minnesota; Kaan A: St. Paul’s Hospital, Vancouver, British Columbia, Canada; Kusne S: Mayo Clinic Arizona, Phoenix, Arizona; Loebe M: Methodist Hospital, Houston, Texas; Massicotte P: University of Alberta, Stollery Children’s Hospital, Edmonton, Alberta, Canada; Moazami N: Minneapolis Heart Institute, Minneapolis, Minnesota; Mohacsi P: University Hospital, Bern, Switzerland; Mooney M: Sentara Norfolk, Virginia Beach, Virginia; Nelson T: Mayo Clinic Arizona, Phoenix, Arizona; Pagani F: University of Michigan, Ann Arbor, Michigan; Perry W: Integris Baptist Health Care, Oklahoma City, Oklahoma; Potapov EV: Deutsches Herzzentrum Berlin, Berlin, Germany; Rame JE: University of Pennsylvania, Philadelphia, Pennsylvania; Russell SD: Johns Hopkins, Baltimore, Maryland; Sorensen EN: University of Maryland, Baltimore, Maryland; Sun B: Minneapolis Heart Institute, Minneapolis, Minnesota; Strueber M: Hannover Medical School, Hanover, Germany Independent reviewers Mangi AA: Yale University School of Medicine, New Haven, Connecticut; Petty MG: University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota; Rogers J: Duke University Medical Center, Durham, North Carolina

[1]  L. Lund,et al.  Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Verónica Mertz K,et al.  [Perioperative risk among patients with cirrhosis]. , 2010, Revista medica de Chile.

[3]  Farrar Dj,et al.  Ventricular interactions during mechanical circulatory support. , 1994 .

[4]  T. Guy,et al.  The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. , 2007, The Annals of thoracic surgery.

[5]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[6]  J. R. Fitzpatrick,et al.  Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  M. Dew,et al.  Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  I. Raad,et al.  Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. , 2003, Chest.

[9]  宏行 津久井.  Biventricular assist device utilization for patients with morbid congestive heart failure : a justifiable strategy , 2006 .

[10]  L. Miller,et al.  Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park's stitch). , 2004, The Journal of thoracic and cardiovascular surgery.

[11]  V. Lawrence,et al.  Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease. , 1993, Chest.

[12]  H. Vohra,et al.  Best evidence topic - Cardiac general Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes? , 2010 .

[13]  Walter R Wilson,et al.  Nonvalvular cardiovascular device-related infections. , 2004, Clinical Infectious Diseases.

[14]  D. Goff,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardi , 2007, Journal of the American Dental Association.

[15]  E. Lonn,et al.  Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. , 2003, Transfusion medicine reviews.

[16]  D. Moroney,et al.  Outpatient use of left ventricular assist devices: nursing, technical, and educational considerations. , 1997, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[17]  N. Nanda,et al.  Native aortic valve insufficiency in patients with left ventricular assist devices. , 2006, The Annals of thoracic surgery.

[18]  R. Pierson,et al.  Body mass index and outcomes after left ventricular assist device placement. , 2004, The Annals of thoracic surgery.

[19]  S. Chillcott,et al.  Predictors of quality of life at 1 month after implantation of a left ventricular assist device. , 2002, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[20]  M. Oz,et al.  Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. , 1998, The Annals of thoracic surgery.

[21]  M. Morel-Kopp,et al.  Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies. , 2010, Thrombosis research.

[22]  William A. Smith,et al.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system. , 2008, The Journal of thoracic and cardiovascular surgery.

[23]  E. Stephenson,et al.  Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[25]  Ernst Wolner,et al.  Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  S. Tsui,et al.  What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device? , 2012, Interactive cardiovascular and thoracic surgery.

[27]  R. Hetzer,et al.  Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  E. Wouters,et al.  Postoperative Pulmonary Function Abnormalities After Coronary Artery Bypass Surgery , 1993 .

[29]  L. Lund,et al.  Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure. , 2009, The American journal of cardiology.

[30]  Georg Wieselthaler,et al.  Coronary hemodynamics and myocardial oxygen consumption during support with rotary blood pumps. , 2009, Artificial organs.

[31]  W. Kraus,et al.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[32]  M. Oz,et al.  Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  M. Slaughter,et al.  Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  Christoph Benk,et al.  Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  M. Camacho,et al.  Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  G. Lip,et al.  The role of aspirin in cardiovascular prevention: implications of aspirin resistance. , 2008, Journal of the American College of Cardiology.

[37]  E. Bond,et al.  Nursing education and implications for left ventricular assist device destination therapy. , 2004, Progress in cardiovascular nursing.

[38]  J. Greenhouse,et al.  Meta‐analysis of risk for relapse to substance use after transplantation of the liver or other solid organs , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[39]  D. Farrar,et al.  Right heart interaction with the mechanically assisted left heart , 1985, World Journal of Surgery.

[40]  W. Cohn,et al.  A felt plug simplifies left ventricular assist device removal after successful bridge to recovery. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  A. Rahmel,et al.  The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  M. Simon,et al.  Impact of renal function before mechanical circulatory support on posttransplant renal outcomes. , 2011, The Annals of thoracic surgery.

[43]  W. Frishman,et al.  Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure , 2007 .

[44]  K. Bramstedt,et al.  When death is the outcome of informed refusal: dilemma of rejecting ventricular assist device therapy. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  T. Nakatani,et al.  Late aortic insufficiency related to poor prognosis during left ventricular assist device support. , 2011, The Annals of thoracic surgery.

[46]  M. Oz,et al.  Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  A. Gristina,et al.  Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs tissue integration. , 1988, JAMA.

[48]  B Bunzel,et al.  Solid Organ Transplantation: Are there Predictors for Posttransplant Noncompliance? A Literature Overview , 2000, Transplantation.

[49]  L. Stevenson,et al.  Third INTERMACS Annual Report: the evolution of destination therapy in the United States. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  Mark S. Slaughter,et al.  Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection , 2007, Circulation.

[51]  B. Pitt,et al.  Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. , 1986, American heart journal.

[52]  A. Boyle,et al.  Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. , 2011, The Annals of thoracic surgery.

[53]  J. Kirklin,et al.  Comparison of Observed Survival After Ventricular Assist Device Placement Versus Predicted Survival Without Assist Device Using the Seattle Heart Failure Model , 2012, ASAIO journal.

[54]  J. Felner,et al.  Mitral Valve Stenosis , 2010 .

[55]  Ashish S Shah,et al.  Evaluation of risk indices in continuous-flow left ventricular assist device patients. , 2009, The Annals of thoracic surgery.

[56]  M. Oz,et al.  Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[57]  W. Abraham,et al.  Management Strategies for Stage‐D Patients with Acute Heart Failure , 2008, Clinical cardiology.

[58]  James O. Mudd,et al.  Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[59]  Nader Moazami,et al.  Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. , 2007, The Annals of thoracic surgery.

[60]  J. Hiatt,et al.  Surgical Procedures for Patients Receiving Mechanical Cardiac Support , 2011, The American surgeon.

[61]  Karen Ulisney,et al.  INTERMACS profiles of advanced heart failure: the current picture. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[62]  J. Shuhaiber,et al.  The influence of preoperative use of ventricular assist devices on survival after heart transplantation: propensity score matched analysis , 2010, BMJ : British Medical Journal.

[63]  M. McConnell,et al.  Mitral Valve Insufficiency , 2008 .

[64]  R. Hetzer,et al.  Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[65]  G. Hartman,et al.  Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. , 1998, The Journal of thoracic and cardiovascular surgery.

[66]  Marc A Simon,et al.  Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients. , 2012, Journal of cardiac failure.

[67]  J. Menzoian,et al.  Coronary artery bypass grafting in patients with cerebrovascular disease. , 1998, The Annals of thoracic surgery.

[68]  B. Reichart,et al.  Platelet activation markers in patients with heart assist device. , 2005, Artificial organs.

[69]  A. Mcgrady,et al.  Effects of Depression and Anxiety on Adherence to Cardiac Rehabilitation , 2009, Journal of cardiopulmonary rehabilitation and prevention.

[70]  Z. Demirozu,et al.  Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[71]  D. Morgan,et al.  Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? , 1992, The Lancet.

[72]  R. Califf,et al.  Association of depression and survival in patients with chronic heart failure over 12 Years. , 2012, Psychosomatics.

[73]  P. MarioConcha,et al.  Riesgo perioperatorio en pacientes con cirrosis hepática , 2010 .

[74]  Hosakote M Nagaraj,et al.  Use of a vascular plug to percutaneously occlude the outflow conduit of a dysfunctional left ventricular assist device. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[75]  S. Chillcott,et al.  Change in quality of life from before to after discharge following left ventricular assist device implantation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[76]  J. Levenson,et al.  Psychosocial evaluation of heart transplant candidates: an international survey of process, criteria, and outcomes. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[77]  D. Renlund,et al.  Consensus statement: Palliative and supportive care in advanced heart failure. , 2004, Journal of cardiac failure.

[78]  S. Smith,et al.  Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. , 1997, Circulation.

[79]  M. Oz,et al.  Surgical management of valvular disease in patients requiring left ventricular assist device support. , 2001, The Annals of thoracic surgery.

[80]  Igor D Gregoric,et al.  Is native aortic valve commissural fusion in patients with long-term left ventricular assist devices associated with clinically important aortic insufficiency? , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[81]  T. Horan,et al.  Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.

[82]  J. Casida,et al.  From Insiders' Perspectives: Adjusting to Caregiving for Patients with Left Ventricular Assist Devices , 2011 .

[83]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[84]  Larry M Baddour,et al.  Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card , 2007, Circulation.

[85]  F. Dobbels,et al.  Adherence to the Therapeutic Regimen in Heart, Lung, and Heart‐Lung Transplant Recipients , 2005, The Journal of cardiovascular nursing.

[86]  B. Culver.  How Should the Lower Limit of the Normal Range Be Defined? , 2012, Respiratory Care.

[87]  R. Benza,et al.  Infection during circulatory support with ventricular assist devices. , 1999, The Annals of thoracic surgery.

[88]  R. Hajjar,et al.  Ventricular Arrhythmias after Left Ventricular Assist Device Implantation , 2008, Pacing and clinical electrophysiology : PACE.

[89]  Q. Young,et al.  Emotional Experiences of Caregivers of Patients with a Ventricular Assist Device , 2010 .

[90]  D. Pennington,et al.  Noncardiac operations in patients supported with mechanical circulatory support devices. , 1994, Journal of the American College of Surgeons.

[91]  A Mattea,et al.  Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[92]  M. Slaughter,et al.  Home Discharge Experience With the Thoratec TLC-II Portable Driver , 2007, ASAIO journal.

[93]  D. Dudzinski,et al.  Ethics guidelines for destination therapy. , 2006, The Annals of thoracic surgery.

[94]  F. Morales,et al.  A shuttle walk test for assessment of functional capacity in chronic heart failure. , 1999, American heart journal.

[95]  R. Starling,et al.  Application of the Seattle Heart Failure Model in Ambulatory Patients Presented to an Advanced Heart Failure Therapeutics Committee , 2010, Circulation. Heart failure.

[96]  Yoshifumi Naka,et al.  Revised screening scale to predict survival after insertion of a left ventricular assist device. , 2003, The Journal of thoracic and cardiovascular surgery.

[97]  M. Hayney,et al.  Decreased T‐Cell Responses to Influenza Vaccination in Patients with Heart Failure , 2010, Pharmacotherapy.

[98]  L. Lund,et al.  Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. , 2005, The American journal of cardiology.

[99]  D. Speake,et al.  In open heart surgery is there a role for the use of carbon dioxide field flooding techniques to reduce the level of post-operative gaseous emboli? , 2004, Interactive cardiovascular and thoracic surgery.

[100]  A. Stofkova.  Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. , 2009, Endocrine regulations.

[101]  R. Benza,et al.  Infection in ventricular assist devices: prevention and treatment. , 2003, The Annals of thoracic surgery.

[102]  S. Russell,et al.  Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[103]  O. Frazier,et al.  End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[104]  P. Moons,et al.  Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[105]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[106]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text , 2006 .

[107]  O. Frazier,et al.  Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[108]  G. Ewald,et al.  Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy , 2012, Circulation. Heart failure.

[109]  M. Firstenberg,et al.  Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[110]  L. Saxon,et al.  Ventricular Tachycardia in the Era of Ventricular Assist Devices , 2011, Journal of cardiovascular electrophysiology.

[111]  E. Núñez,et al.  Low lymphocyte count and cardiovascular diseases. , 2011, Current medicinal chemistry.

[112]  M. Loebe,et al.  Early mobilization of LVAD recipients who require prolonged mechanical ventilation. , 2006, Texas Heart Institute journal.

[113]  Ernst Wolner,et al.  Platelet dysfunction in outpatients with left ventricular assist devices. , 2009, The Annals of thoracic surgery.

[114]  N. Uriel,et al.  A successful pregnancy during mechanical circulatory device support. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[115]  N. Oda,et al.  Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. -Single center's experience in japan-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[116]  Jonathan W Haft,et al.  Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality , 2010, Circulation.

[117]  W. Cohn,et al.  Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. , 2008, The Annals of thoracic surgery.

[118]  M. Morshuis,et al.  Triple bridge-to-transplant in a case of giant cell myocarditis complicated by human leukocyte antigen sensitization and heparin-induced thrombocytopenia type II. , 2006, The Annals of thoracic surgery.

[119]  T. Myers,et al.  Myocardial perfusion as assessed by positron emission tomography during long-term mechanical circulatory support. , 2006, Congestive heart failure.

[120]  Dong Chen,et al.  Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. , 2010, The Annals of thoracic surgery.

[121]  J. R. Fitzpatrick,et al.  Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. , 2009, The Journal of thoracic and cardiovascular surgery.

[122]  R. Padera.  Infection in ventricular assist devices: the role of biofilm. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[123]  M Flannery,et al.  Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. , 1998, Circulation.

[124]  Francis D. Pagani,et al.  The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported Patients , 2010, Circulation. Heart failure.

[125]  C. Rihal,et al.  Mitral regurgitation in patients with advanced systolic heart failure. , 2004, Journal of cardiac failure.

[126]  S. Russell,et al.  Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[127]  Y. Toyoda,et al.  Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes. , 2011, The Annals of thoracic surgery.

[128]  Wayne C Levy,et al.  Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[129]  Robert L Kormos,et al.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[130]  C. Zigelman,et al.  Aortic valve stenosis. , 2009, Anesthesiology clinics.

[131]  M. Oz,et al.  Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. , 2002, The Annals of thoracic surgery.

[132]  M. Flattery,et al.  Cellular immunity impaired among patients on left ventricular assist device for 6 months. , 2008, The Annals of thoracic surgery.

[133]  T. Snyder,et al.  Successful percutaneous management of acute left ventricular assist device stoppage. , 2010, ASAIO journal.

[134]  M. Blood,et al.  Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[135]  A. Contractor.  Cardiac rehabilitation after myocardial infarction. , 2011, The Journal of the Association of Physicians of India.

[136]  O. Ponzio,et al.  Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[137]  D. Kiely,et al.  The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension. , 2006, QJM : monthly journal of the Association of Physicians.

[138]  Andrew Boyle,et al.  Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. , 2009, The Journal of thoracic and cardiovascular surgery.

[139]  D. Goldstein,et al.  Left ventricular assist devices and bleeding: adding insult to injury. , 2003, The Annals of thoracic surgery.

[140]  S. Goldman,et al.  Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. , 2008, The Annals of thoracic surgery.

[141]  L. Miller,et al.  Cardiac assist device infections , 2009, Current infectious disease reports.

[142]  Markus J. Wilhelm,et al.  Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator , 2002, Circulation.

[143]  A. Winkler,et al.  Heparin-induced thrombocytopenia and cardiac surgery , 2010, Current opinion in anaesthesiology.

[144]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[145]  Robert L Kormos,et al.  Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[146]  S. Russell,et al.  Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[147]  R. Dodd.  Emerging Pathogens in Transfusion Medicine , 2010, Clinics in Laboratory Medicine.

[148]  R. Hetzer,et al.  A titanium plug simplifies left ventricular assist device removal after myocardial recovery. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[149]  R. Pierson,et al.  Diabetes and outcomes after left ventricular assist device placement. , 2005, Journal of cardiac failure.

[150]  G. Guyatt,et al.  Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. , 1988 .

[151]  O. Frazier,et al.  Myocardial Hemodynamics, Physiology, and Perfusion With an Axial Flow Left Ventricular Assist Device in the Calf , 2004, ASAIO journal.

[152]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[153]  M. Slaughter,et al.  Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device , 2010, Circulation. Heart failure.

[154]  F. Pagani,et al.  Maximal oxygen uptake improvements with long-term LVAD support , 2005 .

[155]  Roland Hetzer,et al.  Long-term biventricular support with the heartware implantable continuous flow pump. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[156]  F. Beyersdorf,et al.  Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[157]  M. Selim.  Angioplasty and stenting of asymptomatic carotid stenosis before cardiac surgery: more study is needed. , 2008, Archives of neurology.

[158]  Christopher M O'Connor,et al.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. , 2010, Journal of the American College of Cardiology.

[159]  N. Uriel,et al.  Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices , 2011, European journal of heart failure.

[160]  F. Fedele,et al.  Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study , 2006, Journal of Cardiovascular Medicine.

[161]  A. Eshelman,et al.  LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant , 2009, Heart Failure Reviews.

[162]  P. Houck,et al.  The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration. , 2006, The Annals of thoracic surgery.

[163]  F. Biancari,et al.  Does the use of carbon dioxide field flooding during heart valve surgery prevent postoperative cerebrovascular complications? , 2009, Interactive cardiovascular and thoracic surgery.

[164]  M. Bartels,et al.  Exercise, cardiovascular disease, and chronic heart failure. , 2001, Archives of physical medicine and rehabilitation.

[165]  A. Busti,et al.  Evidence-based treatment recommendations for uremic bleeding , 2007, Nature Clinical Practice Nephrology.

[166]  Yoshifumi Naka,et al.  Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[167]  R. Salamonsen,et al.  Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. , 2009, Heart, lung & circulation.

[168]  M. Hravnak,et al.  Management of chronic left ventricular assist device percutaneous lead insertion sites. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[169]  D. Mancini,et al.  Peak VO(2): a simple yet enduring standard. , 2000, Circulation.

[170]  M. Borger,et al.  Early changes in bioprosthetic heart valves following ventricular assist device implantation. , 2007, International journal of cardiology.

[171]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[172]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[173]  F. Sabol,et al.  Use of left ventricle assist device in a pregnant woman with acute aortic and coronary dissections. , 2010, Interactive cardiovascular and thoracic surgery.

[174]  T. Myers,et al.  Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[175]  R. Hetzer,et al.  Bridging-to-recovery. , 2001, The Annals of thoracic surgery.

[176]  Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[177]  Deborah Budge,et al.  Obesity and Left Ventricular Assist Device Driveline Exit Site Infection , 2010, ASAIO journal.

[178]  Nader Moazami,et al.  Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. , 2010, The Journal of thoracic and cardiovascular surgery.

[179]  J. Dubois,et al.  Teaching documentation tool: building a successful discharge. , 2003, Critical care nurse.

[180]  K. Sharp,et al.  Management of General Surgical Problems in Patients with Left Ventricular Assist Devices , 2006, The American surgeon.

[181]  R. Albert,et al.  Preoperative evaluation of the patient with pulmonary disease. , 2007, Chest.

[182]  M. Persson,et al.  Effect of CO2 Insufflation on the Number and Behavior of Air Microemboli in Open-Heart Surgery: A Randomized Clinical Trial , 2004, Circulation.

[183]  D. Matamis,et al.  Inhaled NO and Sildenafil Combination in Cardiac Surgery Patients With Out-of-Proportion Pulmonary Hypertension: Acute Effects on Postoperative Gas Exchange and Hemodynamics , 2012, Circulation. Heart failure.

[184]  J. Gorcsan,et al.  Left ventricular remodeling and myocardial recovery on mechanical circulatory support. , 2010, Journal of cardiac failure.

[185]  L. Arusoglu,et al.  Suicide after ventricular assist device implantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[186]  R. Leyh,et al.  Heartmate II Implantation with Right Coronary Bypass Grafting in Ischemic Cardiomyopathy with “Fixed” Pulmonary Hypertension: Treatment Strategy to Protect Right Ventricular Function , 2010, Journal of cardiac surgery.

[187]  Kenneth A Ellenbogen,et al.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe , 2011, Journal of the American College of Cardiology.

[188]  M. Slaughter,et al.  Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[189]  J. Pincemail,et al.  SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery. , 2000, The Annals of thoracic surgery.

[190]  F. Pagani,et al.  The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. , 2008, Journal of the American College of Cardiology.

[191]  Lippincott Williams Wilkins,et al.  Cardiac rehabilitation programs. A statement for healthcare professionals from the American Heart Association. , 1994, Circulation.

[192]  L. Stevenson,et al.  Keeping Left Ventricular Assist Device Acceleration on Track , 2011, Circulation.

[193]  S. Russell,et al.  Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[194]  M. Oz,et al.  Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[195]  M. Oz,et al.  Noncardiac Surgery in Long‐Term Implantable Left Ventricular Assist‐Device Recipients , 1995, Annals of surgery.

[196]  R. Adamson,et al.  Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[197]  D. Renlund,et al.  Outcome of noncardiac surgery in patients with ventricular assist devices. , 2009, The American journal of cardiology.

[198]  L. Lund,et al.  Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation. , 2010, The American journal of cardiology.

[199]  P. McCarthy,et al.  Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. , 2001, The Annals of thoracic surgery.

[200]  J. Levenson,et al.  Psychiatric aspects of heart transplantation. , 1993, Psychosomatics.

[201]  Reed Humphrey.  Exercise physiology in patients with left ventricular assist devices. , 1997, Journal of cardiopulmonary rehabilitation.

[202]  Nir Uriel,et al.  Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[203]  Finn Gustafsson,et al.  Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[204]  J. Levenson,et al.  Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. , 1993, Psychosomatics.

[205]  J. Levenson,et al.  Psychological assessment and care of organ transplant patients. , 2002, Journal of consulting and clinical psychology.

[206]  J. Cleveland,et al.  Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[207]  Michael R Pinsky,et al.  Cardiovascular issues in respiratory care. , 2005, Chest.

[208]  W. Henderson,et al.  Multifactorial Risk Index for Predicting Postoperative Respiratory Failure in Men After Major Noncardiac Surgery , 2000, Annals of surgery.

[209]  R. Shemin,et al.  Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume. , 1998, The Annals of thoracic surgery.

[210]  H. Nägele,et al.  Smoking after heart transplantation: an underestimated hazard? , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[211]  D. van Dijk,et al.  Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. , 2000, The Journal of thoracic and cardiovascular surgery.

[212]  Hotta Ss.  Cardiac rehabilitation programs. , 1991 .

[213]  Kiyotaka Fukamachi,et al.  Predictors of Severe Right Ventricular Failure After Implantable Left Ventricular Assist Device Insertion: Analysis of 245 Patients , 2002, Circulation.

[214]  A. Koster,et al.  Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? , 2009, The Annals of thoracic surgery.

[215]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[216]  D. Reich,et al.  The anesthetic considerations in patients with ventricular assist devices presenting for noncardiac surgery: a review of eight cases. , 2002, Anesthesia and analgesia.

[217]  T. Ryan,et al.  Perioperative predictors of extubation failure and the effect on clinical outcome after cardiac surgery. , 1999, Critical care medicine.

[218]  D. Yuh,et al.  PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support , 2008, Circulation. Heart failure.

[219]  L. Miller,et al.  Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[220]  M. Ward,et al.  Chronic septal infarction confers right ventricular protection during mechanical left ventricular unloading. , 2009, The Journal of thoracic and cardiovascular surgery.

[221]  J. Verheijde,et al.  Philosophy, Ethics, and Humanities in Medicine Ethical Challenges with the Left Ventricular Assist Device as a Destination Therapy , 2008 .

[222]  F. Pagani,et al.  Multicenter Experience: Prevention and Management of Left Ventricular Assist Device Infections , 2005, ASAIO journal.

[223]  E. Catena,et al.  Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[224]  Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. , 1992 .

[225]  P. Ponikowski,et al.  Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology , 2009, European journal of heart failure.

[226]  G. Smetana.  Preoperative pulmonary evaluation. , 1999, The New England journal of medicine.

[227]  G. Couper,et al.  Infection in permanent circulatory support: experience from the REMATCH trial. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[228]  N. Wenger,et al.  When withdrawal of life-sustaining care does more than allow death to take its course: the dilemma of left ventricular assist devices. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[229]  M. Cattaneo.  The use of desmopressin in open‐heart surgery , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[230]  J. Gornbein,et al.  Are red blood cell transfusions associated with nosocomial infections in pediatric intensive care units?* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[231]  R. Salamonsen,et al.  Inhalation of Nitric Oxide Provides Selective Pulmonary Vasodilatation, Aiding Mechanical Cardiac Assist with Thoratec Left Ventricular Assist Device , 1994, Anaesthesia and intensive care.

[232]  J. Moses,et al.  Impella LP 2.5 for Left Ventricular Unloading During Venoarterial Extracorporeal Membrane Oxygenation Support , 2011, Journal of cardiac surgery.

[233]  M H Samore,et al.  Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. , 2000, Circulation.

[234]  B. Carabello.  Mitral valve regurgitation. , 1998, Current problems in cardiology.

[235]  Magdi H. Yacoub,et al.  Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective Study , 2011, Circulation.

[236]  A. Delrossi,et al.  Hemodynamic management of patients in the first 24 hours after cardiac surgery , 2005, Critical care medicine.

[237]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[238]  L. Engström,et al.  The fibrinolytic system in human ascites. , 1995, Scandinavian journal of gastroenterology.

[239]  S. Chillcott,et al.  The Next Treatment Option: Using Ventricular Assist Devices for Heart Failure , 2007, Critical care nursing quarterly.

[240]  Robert M. Adamson,et al.  Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience. , 2011, Journal of the American College of Cardiology.

[241]  M. Morshuis,et al.  European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[242]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[243]  T. Motomura,et al.  Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. , 2005, Artificial organs.

[244]  T. Perl.  Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. , 2003, Surgery.

[245]  M. Olschewski,et al.  The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. , 2004, The Journal of thoracic and cardiovascular surgery.

[246]  Silvia G Priori,et al.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.

[247]  R. Hetzer,et al.  Mechanical Circulatory Support—Results, Developments and Trends , 2011, Journal of cardiovascular translational research.

[248]  B. Spiess,et al.  Blood transfusion: the silent epidemic. , 2001, The Annals of thoracic surgery.

[249]  Olbrisch Me,et al.  Psychosocial evaluation of heart transplant candidates: an international survey of process, criteria, and outcomes. , 1991 .

[250]  R. Hetzer,et al.  Revascularization of the occluded right coronary artery during left ventricular assist device implantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[251]  Khurram Shahzad,et al.  Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[252]  P. Holland,et al.  Transfusion-Related Acute Lung Injury Report of a Clinical Look-Back Investigation , 2002 .

[253]  I. Khalid,et al.  Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. , 2010, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[254]  K. Kamohara,et al.  Phasic coronary blood flow pattern during a continuous flow left ventricular assist support. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[255]  J. Raikhelkar.  Mechanical ventilation for cardiac support. , 2007, Critical care clinics.

[256]  T. Myers,et al.  Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. , 2007, Texas Heart Institute journal.

[257]  K. Holdy,et al.  Nutrition assessment and management of left ventricular assist device patients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[258]  L. Nielsen,et al.  Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). , 2009, Journal of the American College of Cardiology.

[259]  Leslie W. Miller,et al.  Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) , 2004, Circulation.

[260]  W R Jarvis,et al.  Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. , 1999, Infection control and hospital epidemiology.

[261]  J. Kirklin,et al.  Use of Gated Cardiac Computed Tomography Angiography in the Assessment of Left Ventricular Assist Device Dysfunction , 2011, ASAIO journal.

[262]  G. Wieselthaler,et al.  Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners. , 2005, Transplantation proceedings.

[263]  Robert L. Kormos,et al.  Biventricular Assist Device Utilization for Patients with Morbid Congestive Heart Failure: A Justifiable Strategy , 2005, Circulation.

[264]  C. Scurlock,et al.  Impact of new technologies on metabolic care in the intensive care unit , 2009, Current opinion in clinical nutrition and metabolic care.

[265]  M. Lauer,et al.  Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Su , 2005, Circulation.

[266]  D. Mozaffarian,et al.  The Seattle Heart Failure Model: Prediction of Survival in Heart Failure , 2006, Circulation.

[267]  P. Kalowes,et al.  Withdrawal of Cardiac Medications and Devices , 2007, AACN advanced critical care.

[268]  J. Levenson,et al.  Psychosocial assessment of organ transplant candidates. Current status of methodological and philosophical issues. , 1995, Psychosomatics.

[269]  Annetine Gelijns,et al.  Left ventricular assist devices as destination therapy: a new look at survival. , 2005, The Journal of thoracic and cardiovascular surgery.

[270]  N. Uriel,et al.  Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.

[271]  T. Myers,et al.  Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[272]  H. Scheld,et al.  Noncardiac surgery in patients with left ventricular assist devices. , 2001, Surgery.

[273]  L. Miller,et al.  Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. , 2008, The Journal of thoracic and cardiovascular surgery.

[274]  O H Frazier,et al.  Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group , 2007, Circulation.

[275]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[276]  M. Mehra,et al.  Allosensitization in heart transplantation: implications and management strategies , 2003, Current opinion in cardiology.

[277]  T. Myers,et al.  Infectious complications associated with ventricular assist systems. , 2000, ASAIO journal.

[278]  R. Hetzer,et al.  Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[279]  R. Kormos,et al.  Ventricular arrhythmias during left ventricular assist device support. , 2007, The American journal of cardiology.

[280]  Mary A Stahl,et al.  Ventricular assist devices: developing and maintaining a training and competency program. , 2002, The Journal of cardiovascular nursing.

[281]  A. Undar,et al.  First Turkish experience with the MicroMed DeBakey VAD. , 2003, Texas Heart Institute journal.

[282]  G. D. Gass,et al.  Preoperative pulmonary function testing to predict postoperative morbidity and mortality. , 1986, Chest.

[283]  V. Lawrence,et al.  Preoperative Pulmonary Risk Stratification for Noncardiothoracic Surgery: Systematic Review for the American College of Physicians , 2006, Annals of Internal Medicine.

[284]  Jg Copeland,et al.  CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation , 2004 .

[285]  T. Hubert,et al.  Impact of nitric oxide inhalation on right ventricular failure after implantation of Novacor left ventricular assist system. , 1995, The Journal of thoracic and cardiovascular surgery.

[286]  S. Saltissi,et al.  Assessment of a low-intensity cardiac rehabilitation programme using the six-minute walk test , 2001, Clinical rehabilitation.

[287]  A. Moritz,et al.  Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open heart surgery. , 2001, The Annals of thoracic surgery.

[288]  Stefan Fischer,et al.  Using inhaled iloprost to wean from cardiopulmonary bypass after implanting a left ventricular assist device. , 2006, Anesthesia and analgesia.

[289]  T. Elton,et al.  Mechanisms of Disease: detrimental adrenergic signaling in acute decompensated heart failure , 2008, Nature Clinical Practice Cardiovascular Medicine.

[290]  J. Buring,et al.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction. , 1989, Circulation.

[291]  T. Therneau,et al.  Risk factors for mortality after surgery in patients with cirrhosis. , 2007, Gastroenterology.

[292]  L. Gray,et al.  Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.

[293]  T. Myers,et al.  Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. , 2003, The Annals of thoracic surgery.

[294]  L. Stevenson,et al.  62: Strategies for LVAD Therapy in INTERMACS: Intent Rate v. Event Rate , 2010 .

[295]  G. P. Gravlee.  Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation , 2010 .

[296]  Wayne C Levy,et al.  Seattle Heart Failure Model. , 2013, The American journal of cardiology.

[297]  W. Henderson,et al.  Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. , 2004, Journal of the American College of Surgeons.

[298]  C. Scurlock,et al.  Intensive metabolic support: evolution and revolution. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[299]  E. Holmes.  Outpatient management of long-term assist devices. , 2003, Cardiology clinics.

[300]  L. Dembo,et al.  Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[301]  S. Simsir,et al.  Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure. , 2011, Annals of transplantation.

[302]  R. Morris,et al.  Coronary artery bypass grafting in patients with COPD. , 1998, Chest.

[303]  J. Butler,et al.  Utility of the Seattle Heart Failure Model in patients with advanced heart failure. , 2009, Journal of the American College of Cardiology.

[304]  L. Samuels,et al.  Cardiac ventricular support. Considerations for psychiatry. , 1999, Psychosomatics.

[305]  G. Ewald,et al.  Left Ventricular Assist Device in Pregnancy , 2011, Obstetrics and gynecology.

[306]  E. Ryding,et al.  Cardiopulmonary perfusion and cerebral blood flow in bilateral carotid artery disease. , 1991, The Annals of thoracic surgery.

[307]  P. Herijgers,et al.  Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. , 2003, The Thoracic and cardiovascular surgeon.

[308]  B. Griffith,et al.  Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[309]  G. Schuler,et al.  Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.

[310]  T. Elliott,et al.  Regionalized approach to emergency medical services training for the care of patients with mechanical assist devices. , 2010, Progress in transplantation.

[311]  William L Holman,et al.  INTERMACS: interval analysis of registry data. , 2009, Journal of the American College of Surgeons.

[312]  E. Fosse,et al.  Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. , 1997, The Annals of thoracic surgery.

[313]  R. Hershberger,et al.  Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. , 2003, Journal of cardiac failure.

[314]  Sonya L. Irons,et al.  Examination of the Six Minute Walk Test to Determine Functional Capacity in People with Chronic Heart Failure: A Systematic Review , 2010, Cardiopulmonary physical therapy journal.

[315]  C. Russo,et al.  Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[316]  F. Pagani,et al.  Hemodynamic and Exercise Performance With Pulsatile and Continuous-Flow Left Ventricular Assist Devices , 2007, Circulation.

[317]  R. Pierson,et al.  Relationship between renal function and left ventricular assist device use. , 2006, The Annals of thoracic surgery.

[318]  A. Charloux,et al.  Exercise training with a heart device: a hemodynamic, metabolic, and hormonal study. , 2001, Medicine & Science in Sports & Exercise.

[319]  J. Tijssen,et al.  The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience* , 2011, Critical care medicine.

[320]  F. Lowy,et al.  Ventricular assist device-related infections. , 2006, The Lancet. Infectious diseases.

[321]  G. Mudge,et al.  Ventricular assist devices the challenges of outpatient management. , 2009, Journal of the American College of Cardiology.

[322]  M. Jahangiri,et al.  Neurocognitive function and cerebral emboli: randomized study of on-pump versus off-pump coronary artery bypass surgery. , 2007, The Annals of thoracic surgery.

[323]  M. Thompson,et al.  Medical compliance and its predictors in the first year after heart transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[324]  Stuart Russell,et al.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[325]  M. Roizen.  Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: A Randomized Trial , 2010 .

[326]  L. Lund,et al.  Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. , 2007, The American journal of cardiology.

[327]  Rajko Radovancevic,et al.  Increased Leukocyte-Platelet Interactions During Circulatory Support With Left Ventricular Assist Devices , 2009, ASAIO journal.

[328]  A. Jacobs,et al.  Aspirin resistance and atherothrombotic disease. , 2005, Journal of the American College of Cardiology.

[329]  D. Bull,et al.  Patch closure of the aortic anulus in a recipient of a ventricular assist device. , 2000, The Journal of thoracic and cardiovascular surgery.

[330]  Kari A Carter,et al.  Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. , 2011, Mayo Clinic proceedings.

[331]  R. Starling,et al.  Management of left ventricular assist devices after surgery: bridge, destination, and recovery , 2009, Current opinion in cardiology.

[332]  L. Shore-lesserson.  Evidence Based Coagulation Monitors: Heparin Monitoring, Thromboelastography, and Platelet Function , 2005, Seminars in cardiothoracic and vascular anesthesia.

[333]  O. Frazier,et al.  Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[334]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[335]  R. Hetzer,et al.  Prediction of Cardiac Stability After Weaning From Left Ventricular Assist Devices in Patients With Idiopathic Dilated Cardiomyopathy , 2008, Circulation.

[336]  A. Carvalho,et al.  Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. , 2008, The Canadian journal of cardiology.

[337]  S. Chillcott,et al.  Mental health and medical challenges. Management of a depressed patient with a left ventricular assist system in an inpatient psychiatric setting. , 2009, Journal of psychosocial nursing and mental health services.

[338]  H. Ichikawa,et al.  Long-term medical control of inflow cuff infection in a patient with a left ventricular assist system , 2009, Journal of Artificial Organs.

[339]  B. Silbert,et al.  Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial , 2003, Perfusion.

[340]  M. Loebe,et al.  Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. , 1997, Circulation.

[341]  R. Chambers,et al.  Family and social network , 1964 .

[342]  M. Hannan,et al.  Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[343]  R. Berryessa,et al.  Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report , 2001, Perfusion.

[344]  P. Kuo,et al.  Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure. , 2000, Anesthesia and analgesia.

[345]  E. Catena,et al.  Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device. , 2009, American journal of surgery.

[346]  S. Russell,et al.  Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[347]  T. Myers,et al.  Exercise capacity recovers slowly but fully in patients with a left ventricular assist device. , 1996, ASAIO journal.

[348]  M. Morshuis,et al.  Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. , 2006, The Journal of thoracic and cardiovascular surgery.

[349]  M. Simon,et al.  5: Lack of Improvement in Prealbumin at Two Weeks Predicts a Poor Outcome after Mechanical Circulatory Support , 2009 .

[350]  G. Tenderich,et al.  Device and patient management in a bridge-to-transplant setting. , 2001, The Annals of thoracic surgery.

[351]  K. Langa,et al.  Hospital variation in transfusion and infection after cardiac surgery: a cohort study , 2009, BMC medicine.

[352]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[353]  B Bunzel,et al.  Noncompliance in organ transplant recipients: a literature review. , 2000, General hospital psychiatry.

[354]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[355]  T. MacGillivray,et al.  Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation , 2007, Anesthesia and analgesia.

[356]  Dionne A. Graham,et al.  Risk factors for surgical site infection after cardiac surgery in children. , 2010, The Annals of thoracic surgery.

[357]  M. Slaughter,et al.  Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. , 2007, The Journal of thoracic and cardiovascular surgery.

[358]  A. Haverich,et al.  Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. , 2009, The Journal of thoracic and cardiovascular surgery.

[359]  Yoshifumi Naka,et al.  Effects of left ventricular assist device therapy on ventricular arrhythmias. , 2005, Journal of the American College of Cardiology.

[360]  G. Moneta.  Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis , 2010 .

[361]  T. Myers,et al.  Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[362]  S. Hussain,et al.  Pre-operative pulmonary evaluation. , 2005, Journal of Ayub Medical College, Abbottabad : JAMC.

[363]  M. Oz,et al.  Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. , 2004, The Journal of thoracic and cardiovascular surgery.

[364]  Rachel F. Eyler,et al.  Vancomycin Use During Left Ventricular Assist Device Support , 2009, Infection Control & Hospital Epidemiology.

[365]  J D Thomas,et al.  Clinical utility of echocardiography in the management of implantable ventricular assist devices. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[366]  森田 達也.  「緩和ケア」として行われた介入と副次的評価項目であることの限界 (論文を読み,理解する--Early palliative care for patients with metastatic non-small-cell lung cancer) , 2011 .

[367]  L. Czer,et al.  Evaluation of the HeartMate II™ left ventricular assist device in obese heart failure patients: effects on weight loss. , 2011, Annals of transplantation.

[368]  G. Malfatto,et al.  Left-to-right systolic ventricular interaction in patients undergoing biventricular stimulation for dilated cardiomyopathy. , 2010, Journal of applied physiology.

[369]  M. Oz,et al.  Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. , 1995, The Annals of thoracic surgery.

[370]  G. Wollenek,et al.  Heart Transplantation: are there Psychosocial Predictors for Clinical Success of Surgery? , 1994, The Thoracic and cardiovascular surgeon.

[371]  L. Savage,et al.  Developing and maintaining competency with circulatory assist devices: how to meet the challenge. , 2010, Progress in transplantation.

[372]  Y. Tomizawa,et al.  Cardiac rehabilitation and artificial heart devices , 2009, Journal of Artificial Organs.

[373]  T. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. , 1999, American journal of infection control.

[374]  P. Araoz,et al.  CT of left ventricular assist devices. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[375]  T. Kohmoto,et al.  Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy. , 2008, Interactive cardiovascular and thoracic surgery.

[376]  S. Bolling,et al.  Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. , 1999, Circulation.

[377]  A B de la Rivière,et al.  Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? , 2001, Journal of the American College of Cardiology.

[378]  A. Boyle,et al.  Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[379]  J. Kirkpatrick,et al.  Left Ventricular Assist Devices and Other Devices for End-Stage Heart Failure: Utility of Echocardiography , 2010, Current cardiology reports.

[380]  David X M Zhao,et al.  Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest. , 2011, The Journal of invasive cardiology.

[381]  A. Khaghani,et al.  Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery. , 2008, The Journal of thoracic and cardiovascular surgery.

[382]  D. Dunkler,et al.  Renal function and outcome after continuous flow left ventricular assist device implantation. , 2009, The Annals of thoracic surgery.

[383]  M. Slaughter,et al.  70 The HeartMate II Risk Score: Predicting Survival in Candidates for Left Ventricular Assist Device Support , 2011 .

[384]  B. Griffith,et al.  Quality of life outcomes in left ventricular assist system inpatients and outpatients. , 1999, ASAIO journal.

[385]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[386]  I. Dagher,et al.  Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract. , 2001, Gastroenterology.

[387]  D. Farrar,et al.  The thoratec ventricular assist device: a paracorporeal pump for treating acute and chronic heart failure. , 2000, Seminars in thoracic and cardiovascular surgery.

[388]  Paula Marcus.  Left ventricular assist devices: psychosocial challenges in the elderly. , 2009, The Annals of thoracic surgery.

[389]  C. O'connor,et al.  Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. , 2008, American heart journal.

[390]  Gilberto Luis Camanho,et al.  Level of Evidence , 2009, Revista brasileira de ortopedia.

[391]  V. Poirier,et al.  Transition from cardiopulmonary bypass to the HeartMate left ventricular assist device. , 1998, The Annals of thoracic surgery.

[392]  G. Ewald,et al.  Surgical management of Novacor drive-line exit site infections. , 2002, The Annals of thoracic surgery.

[393]  Francis D. Pagani,et al.  Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device , 2009, Circulation.

[394]  S. Raman,et al.  Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[395]  G. Hedenstierna,et al.  Pulmonary Densities during Anesthesia with Muscular Relaxation—A Proposal of Atelectasis , 1985, Anesthesiology.

[396]  M C Oz,et al.  Implantable left ventricular assist devices. , 1998, The New England journal of medicine.

[397]  M. Dew,et al.  Early adverse events as predictors of 1-year mortality during mechanical circulatory support. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[398]  Miyoko Endo,et al.  Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[399]  E R Schmid,et al.  Left ventricular assist device as bridge to heart transplantation--lessons learned with the MicroMed DeBakey axial blood flow pump. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[400]  Gernot Marx,et al.  The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[401]  S. Russell,et al.  Marital status improves survival after orthotopic heart transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[402]  A. Kfoury,et al.  End-of-life decision making and implementation in recipients of a destination left ventricular assist device. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[403]  Ernst Wolner,et al.  Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[404]  J. Thornby,et al.  Risk factors and outcomes of fungal ventricular-assist device infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[405]  R. Kormos,et al.  Cerebrovascular accidents in patients with a ventricular assist device. , 2007, The Journal of thoracic and cardiovascular surgery.

[406]  N. Kapur,et al.  Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. , 2011, The Journal of thoracic and cardiovascular surgery.

[407]  B. Jugdutt,et al.  Mechanical circulatory support for elderly heart failure patients , 2012, Heart Failure Reviews.

[408]  Uwe Tegtbur,et al.  Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[409]  F. Dobbels,et al.  Clinical risk associated with appointment noncompliance in heart transplant recipients. , 2000, Progress in transplantation.

[410]  T. Evans,et al.  Nutritional support in critical care. , 2003, Clinics in chest medicine.

[411]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[412]  D. Loisance,et al.  Platelet activation and aggregation profile in prolonged external ventricular support. , 2004, The Journal of thoracic and cardiovascular surgery.

[413]  M. Oz,et al.  LVAD support in patients with bioprosthetic valves. , 2002, The Annals of thoracic surgery.

[414]  S. Rogers,et al.  Prevention of infective endocarditis' , 1988, British Dental Journal.

[415]  Carmen Gomar,et al.  Prediction of Postoperative Pulmonary Complications in a Population-based Surgical Cohort , 2010, Anesthesiology.

[416]  Akshay S. Desai,et al.  Clinical Predictors of Hepatic Fibrosis in Chronic Advanced Heart Failure , 2010, Circulation. Heart failure.

[417]  R. Toyoshima,et al.  Psychiatric problems of heart transplant candidates with left ventricular assist devices , 2006, Journal of Artificial Organs.

[418]  C. Silliman,et al.  The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. , 2009, Transfusion medicine reviews.

[419]  M. Betjes,et al.  Premature aging of circulating T cells in patients with end-stage renal disease. , 2011, Kidney international.

[420]  H. Scheld,et al.  Effects of exercise during long-term support with a left ventricular assist device. , 1998, Circulation.

[421]  Martin Strueber,et al.  Multicenter evaluation of an intrapericardial left ventricular assist system. , 2011, Journal of the American College of Cardiology.

[422]  Andrew Boyle,et al.  Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.